SEC Filing Summary for BIOFORCE NANOSCIENCES HOLDINGS, INC.

This filing details transactions made by Director Merle Ferguson on April 20, 2026, and April 22, 2026. On April 20, Ferguson acquired 20,580,000 shares of common stock at $0.007 per share and an additional 4,132,000 shares at $0.001 per share, bringing the total post-transaction shares to 26,700,000. Subsequently, on April 22, Ferguson disposed of all 26,700,000 shares at $0.015 per share, resulting in zero shares held post-transaction. These transactions were direct holdings.